tretinoin and Vesico-Ureteral-Reflux

tretinoin has been researched along with Vesico-Ureteral-Reflux* in 2 studies

Other Studies

2 other study(ies) available for tretinoin and Vesico-Ureteral-Reflux

ArticleYear
Gen1 Modulates Metanephric Morphology Through Retinoic Acid Signaling.
    DNA and cell biology, 2019, Volume: 38, Issue:3

    Congenital anomalies of the kidney and urinary tract (CAKUT) are the leading cause of end-stage renal disease in children. Our group has discovered that Holliday Junction resolvase gene Gen1 is a potential candidate gene for CAKUT. Gen1 mutant mice showed CAKUT phenotypes similar to those observed in retinoic acid (RA)-deficient models. The expression of Raldh2, which encodes the key enzyme in RA synthesis, was reduced in Gen1 mutant metanephros through RNA sequencing. By real-time reverse transcription-PCR, the expression of both Raldh2 and downstream Ret was reduced in embryonic day (E) 11.5 Gen1 mutant ureters and E13.5 kidneys, and expression of RA receptor alpha was decreased in E13.5 Gen1 mutant ureters and kidneys. Further studies showed that all-trans retinoic acid (ATRA) rescued solitary kidney phenotype and improved ureteric branching; ATRA should be administered after ureteric budding to avoid increasing the incidence of ectopic budding in Gen1 mutants. Luciferase intensity of RA response element was lower in CHO-K1 cells transfected with Gen1 siRNA than in those transfected with scrambled RNA, and this inhibitory effect could be reversed by ATRA. These findings indicate that Gen1 mutation can result in renal malformation through RA signaling and Gen1-loss-induced CAKUT can be partly rescued by ATRA.

    Topics: Animals; CHO Cells; Cricetulus; Disease Models, Animal; Holliday Junction Resolvases; Kidney; Mice; Mutation; Signal Transduction; Tretinoin; Urinary Tract; Urogenital Abnormalities; Vesico-Ureteral Reflux

2019
Anorectal and urinary anomalies and aberrant retinoic acid metabolism in cytochrome P450 oxidoreductase deficiency.
    Molecular genetics and metabolism, 2010, Volume: 100, Issue:3

    Cytochrome P450 oxidoreductase (POR) is an electron donor for all microsomal P450 enzymes including CYP26 involved in inactivation of all-trans retinoic acid (atRA). Although previous studies in Por knockout mice suggest that atRA accumulation is relevant to various posterior organ abnormalities, a systematic analysis has not been performed for anorectal and urinary anomalies in patients with POR deficiency (PORD).. To report the frequencies of anorectal and urinary anomalies and plasma atRA values in PORD patients.. We studied 37 Japanese patients with PORD, consisting of 15 homozygotes for R457H (group A), 15 compound heterozygotes for R457H and one apparently null mutation (group B), and seven patients with other combinations of mutations (group C). Since R457H is a severe hypomorphic mutation, the residual POR function is predicted to be higher in group A than in group B.. Imperforate anus was observed in four patients (10.8%) and vesicoureteral reflux was found in three patients (8.1%), with no significant difference in the frequencies of such anomalies between groups A and B. In addition, a complex urogenital malformation including penile agenesis was identified in one patient. Plasma atRA values were above the reference range in nine of 12 patients examined, and were similar between groups A and B and between patients with and without anomalies.. The results imply that aberrant atRA metabolism due to CYP26 deficiency underlies various anorectal and urinary anomalies in patients with PORD. Clinical phenotypes may be primarily determined by maternal oral retinol intake during pregnancy, and plasma atRA values may be largely influenced by the amount of postnatal oral retinol intake in such patients.

    Topics: Adolescent; Animals; Anus, Imperforate; Child; Child, Preschool; Cytochrome P-450 Enzyme System; Female; Heterozygote; Homozygote; Humans; Infant; Infant, Newborn; Intestine, Large; Male; Mice; Mutation; NADPH-Ferrihemoprotein Reductase; Pregnancy; Retinoic Acid 4-Hydroxylase; Tretinoin; Urinary Tract; Urogenital Abnormalities; Vesico-Ureteral Reflux

2010